☆ 4.6 Review

Trimethylamine N-Oxide Levels in Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

METABOLITES (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biochemistry & Molecular Biology

Changes of flavin-containing monooxygenases and trimethylamine-N-oxide may be involved in the promotion of non-alcoholic fatty liver disease by intestinal microbiota metabolite trimethylamine

Chunxia Shi et al.

Summary: This study explored the role of trimethylamine (TMA) in nonalcoholic fatty liver disease (NAFLD) and found that TMA and its metabolite trimethylamine-N-oxide (TMAO) are closely related to NAFLD. The expression of flavin-containing monooxygenase 1 (FMO1) was increased in NAFLD, and FMO1 and its metabolite TMAO were induced by high fat and TMA. However, silencing FMO1 blocked the effects of high fat and TMA on TMAO. Furthermore, TMAO may exert its role in NAFLD through the activation of unfolded protein response (UPR).

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression

Lorenzo A. Orci et al.

Summary: Nonalcoholic fatty liver disease (NAFLD) may be a risk factor for hepatocellular carcinoma (HCC), and this study used meta-analysis to analyze the incidence rates of HCC in NAFLD patients. The results showed that NAFLD patients with cirrhosis have a similar risk of developing HCC compared to cirrhosis patients with other causes. However, the incidence of HCC in nonalcoholic steatohepatitis or simple steatosis patients is lower.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

添加到收藏夹

Review Nutrition & Dietetics

Role of the gut microbiome in chronic diseases: a narrative review

Amrita Vijay et al.

EUROPEAN JOURNAL OF CLINICAL NUTRITION (2022)

添加到收藏夹

Article Nutrition & Dietetics

Lower plasma glutathione, choline, and betaine concentrations are associated with fatty liver in postmenopausal women

Agata Muzsik-Kazimierska et al.

Summary: This study investigated the relationship between one carbon metabolism and biomarkers of nonalcoholic fatty liver disease in postmenopausal women. The findings suggest that lower concentrations of GSH, choline, and betaine are associated with an increased risk of fatty liver.

NUTRITION RESEARCH (2022)

添加到收藏夹

Review Nutrition & Dietetics

Gut microbiota-derived metabolite trimethylamine-N-oxide and multiple health outcomes: an umbrella review and updated meta-analysis

Doudou Li et al.

Summary: This study aimed to summarize the health outcomes related to circulating TMAO concentrations. It identified 6 associations with highly suggestive evidence, suggesting that TMAO may be a novel biomarker for human health conditions including all-cause mortality, hypertension, cardiovascular diseases, diabetes mellitus, cancer, and kidney function.

AMERICAN JOURNAL OF CLINICAL NUTRITION (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Possible correlation between high circulatory levels of trimethylamine-N-oxide and 2177G>C polymorphisms of hepatic flavin containing monooxygenase 3 in Kurdish Population with non-alcoholic fatty liver disease

Mohammad Moradzad et al.

Summary: This study found that circulating TMAO levels were higher in Kurdish patients with NAFLD, and its presence may be correlated with the specific genotype -2177G>C of FMO3.

MOLECULAR BIOLOGY REPORTS (2022)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Association Between Non-alcoholic Fatty Liver Disease and Risk of Stroke: A Systematic Review and Meta-Analysis

Meng Wang et al.

Summary: A meta-analysis study found that non-alcoholic fatty liver disease (NAFLD) is associated with a mildly increased risk of stroke, but there is insufficient evidence to support the proposed association between NAFLD-fibrosis and an increased risk of stroke. Well-designed prospective studies considering specific populations, stroke types, and confounding factors are needed to better understand this association.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

添加到收藏夹

Review Biology

Endothelial Dysfunction in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Panagiotis Theofilis et al.

Summary: Individuals with nonalcoholic fatty liver disease (NAFLD) have an increased cardiovascular risk, and endothelial dysfunction may play a key role in this association. This systematic review and meta-analysis found that NAFLD patients had significantly lower flow-mediated dilation (FMD) values in the brachial artery, indicating endothelial dysfunction.

LIFE-BASEL (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Metabolic Dysfunction-Associated Fatty Liver Disease in the National Health and Nutrition Examination Survey 2017-2020: Epidemiology, Clinical Correlates, and the Role of Diagnostic Scores

Panagiotis Theofilis et al.

Summary: The establishment of metabolic dysfunction-associated fatty liver disease (MAFLD) has led to a reevaluation of its epidemiology, diagnosis, and clinical implications. The study found a high prevalence of MAFLD and identified the fatty liver index as a reliable indicator for MAFLD and significant fibrosis.

METABOLITES (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations

Panagiotis Theofilis et al.

Summary: The proposed nomenclature change from NAFLD to MAFLD has led to a reassessment of its epidemiological trends and associations, revealing a close link between MAFLD and CKD. This association can be attributed to shared risk factors and molecular mechanisms. Treatment options for MAFLD and CKD may include obesity management and novel antidiabetic agents, with alternative approaches showing promise for the future.

WORLD JOURNAL OF GASTROENTEROLOGY (2022)

添加到收藏夹

Review Immunology

Immunological mechanisms and therapeutic targets of fatty liver diseases

Hua Wang et al.

Summary: ALD and NAFLD are two major types of chronic liver diseases worldwide, with inflammation playing a key role in their pathogenesis. Different immunological mechanisms and therapeutic targets are involved in the inflammation associated with fatty liver diseases, leading to differences in the progression of ASH and NASH. Multiple cell types in the liver, as well as microRNAs, extracellular vesicles, and complement, contribute to the inflammatory process in fatty liver diseases.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease

Arun J. Sanyal et al.

Summary: In this study involving patients with nonalcoholic fatty liver disease, advanced fibrosis stages F3 and F4 were associated with increased risks of liver-related complications and death over a median of 4 years of follow-up. Advanced fibrosis was also related to an increased incidence of liver decompensation events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Trimethylamine-N-Oxide Pathway: A Potential Target for the Treatment of MAFLD

Xun Li et al.

Summary: TMAO is a molecular metabolite derived from gut flora and has emerged as a candidate risk factor for MAFLD. It is mainly derived from the gut where gut microbiota converts TMA precursors into TMA, which is then transformed into TMAO in the liver. High-nutrient diets rich in TMA precursors are the main sources of TMAO and can directly affect energy metabolism in the liver, promoting the development of MAFLD.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Circulating trimethylamine-N-oxide is associated with all-cause mortality in subjects with nonalcoholic fatty liver disease

Jose L. Flores-Guerrero et al.

Summary: This study revealed that plasma concentrations of TMAO were associated with all-cause mortality in subjects with NAFLD, independently of traditional risk factors. However, such an association was not present in subjects without NAFLD.

LIVER INTERNATIONAL (2021)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction

Husam M. Salah et al.

Summary: This paper provides an in-depth review of the relationship between HFpEF and NAFLD, proposing three NAFLD-related HFpEF phenotypes and discussing diagnostic challenges and treatment options. The authors suggest that NAFLD-related HFpEF should be recognized as a distinct HFpEF phenotype.

JACC-BASIC TO TRANSLATIONAL SCIENCE (2021)

添加到收藏夹

Review Medicine, General & Internal

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The PRISMA statement was designed to help systematic reviewers transparently report the purpose, methods, and findings of their reviews. The updated PRISMA 2020 statement includes new reporting guidance, a 27-item checklist, an abstract checklist, and revised flow diagrams for reviews.

BMJ-BRITISH MEDICAL JOURNAL (2021)

添加到收藏夹

Article Medicine, General & Internal

Gut-flora metabolites is not associated with synchronous carotid artery plaque and non-alcoholic fatty liver disease in asymptomatic adults A STROBE-compliant article

Ying-Chun Lin et al.

Summary: The synchronous occurrence of non-alcoholic fatty liver disease (NAFLD) and carotid artery plaque formation in patients significantly increases the risk of mortality, especially in individuals with elevated BMI, high blood pressure, and triglyceride levels. Host metabolic status is closely associated with the synchronous presence of NAFLD and carotid artery plaque, highlighting the importance of aggressive management strategies targeting weight reduction, blood pressure control, and triglyceride levels in patients with NAFLD.

MEDICINE (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Non-alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study

Dong Hyun Sinn et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)

添加到收藏夹

Review Nutrition & Dietetics

The Gut Microbial Metabolite Trimethylamine N-Oxide and Hypertension Risk: A Systematic Review and Dose-Response Meta-analysis

Xinyu Ge et al.

ADVANCES IN NUTRITION (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease

Gordon Smith et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

添加到收藏夹

Review Endocrinology & Metabolism

Gut microbiota-derived metabolite trimethylamine N-oxide (TMAO) potentially increases the risk of obesity in adults: An exploratory systematic review and dose-response meta- analysis

Parvin Dehghan et al.

OBESITY REVIEWS (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease

Ze Chen et al.

FREE RADICAL BIOLOGY AND MEDICINE (2020)

添加到收藏夹

Review Cell Biology

Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives

Natascha Roehlen et al.

CELLS (2020)

添加到收藏夹

Review Immunology

The intestinal microbiota fuelling metabolic inflammation

Herbert Tilg et al.

NATURE REVIEWS IMMUNOLOGY (2020)

添加到收藏夹

Review Endocrinology & Metabolism

Obesity: global epidemiology and pathogenesis

Matthias Blueher

NATURE REVIEWS ENDOCRINOLOGY (2019)

添加到收藏夹

Review Endocrinology & Metabolism

Gut microbe-generated metabolite trimethylamine N-oxide and the risk of diabetes: A systematic review and dose-response meta-analysis

Rulin Zhuang et al.

OBESITY REVIEWS (2019)

添加到收藏夹

Article Food Science & Technology

Trimethylamine N-Oxide Aggravates Liver Steatosis through Modulation of Bile Acid Metabolism and Inhibition of Farnesoid X Receptor Signaling in Nonalcoholic Fatty Liver Disease

Xuying Tan et al.

MOLECULAR NUTRITION & FOOD RESEARCH (2019)

添加到收藏夹

Article Endocrinology & Metabolism

Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition

Pouya Saeedi et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2019)

添加到收藏夹

Review Pharmacology & Pharmacy

The unfolded protein response and hepatic lipid metabolism in non alcoholic fatty liver disease

Myeong Jun Song et al.

PHARMACOLOGY & THERAPEUTICS (2019)

添加到收藏夹

Review Gastroenterology & Hepatology

Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease

Cynthia Lebeaupin et al.

JOURNAL OF HEPATOLOGY (2018)

添加到收藏夹

Article Nutrition & Dietetics

Trimethylamine-N-oxide (TMAO) as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome

Luigi Barrea et al.

NUTRIENTS (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Development and Regression of Cirrhosis

Francesca Saffioti et al.

DIGESTIVE DISEASES (2016)

添加到收藏夹

Article Food Science & Technology

Hepatotoxicity and endothelial dysfunction induced by high choline diet and the protective effects of phloretin in mice

Daoyuan Ren et al.

FOOD AND CHEMICAL TOXICOLOGY (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Associations of gut-floradependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults

Yu-ming Chen et al.

SCIENTIFIC REPORTS (2016)

添加到收藏夹

Article Medicine, General & Internal

Nonalcoholic fatty liver disease

Elizabeth M. Brunt et al.

NATURE REVIEWS DISEASE PRIMERS (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Richness of human gut microbiome correlates with metabolic markers

Emmanuelle Le Chatelier et al.

NATURE (2013)

添加到收藏夹

Article Biochemistry & Molecular Biology

Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis

Robert A. Koeth et al.

NATURE MEDICINE (2013)

添加到收藏夹

Article Multidisciplinary Sciences

A metagenome-wide association study of gut microbiota in type 2 diabetes

Junjie Qin et al.

NATURE (2012)

添加到收藏夹

Article Gastroenterology & Hepatology

New insights into the pathophysiology of nonalcoholic fatty liver disease

Norberto C. Chavez-Tapia et al.

ANNALS OF HEPATOLOGY (2009)

添加到收藏夹

Article Multidisciplinary Sciences

An obesity-associated gut microbiome with increased capacity for energy harvest

Peter J. Turnbaugh et al.

NATURE (2006)

添加到收藏夹

Article Multidisciplinary Sciences

Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice

Marc-Emmanuel Dumas et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

添加到收藏夹

Review Medicine, General & Internal

Gut flora in health and disease

F Guarner et al.

LANCET (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.